NCT02249338View on ClinicalTrials.gov

Effect of BIIL 284 BS on Patients With Chronic Obstructive Pulmonary Disease (COPD)

PHASE2CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

October 31, 1999

Primary Completion Date

April 30, 2000

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

BIIL 284 BS

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY